Hims vs. Ro for Weight Loss: GLP-1 Pricing & Medications

Choosing an online weight-loss program can be confusing, especially with major telehealth companies offering access to GLP-1 medications. In 2026, the comparison between Hims and Ro has changed significantly because both platforms have shifted their focus toward branded medications.

The biggest difference is straightforward: Hims has moved away from compounded GLP-1s and now focuses on branded treatments, while Ro offers a broader selection of branded GLP-1 medications alongside a more comprehensive medical-care model.

That difference affects everything from medication choices and pricing to insurance support and the overall patient experience.

So, which platform is better for weight loss? The answer depends on what matters most to you.

Hims vs. Ro: What's the Main Difference in 2026?

The biggest change for Hims is its move toward branded GLP-1 medications following its March 2026 settlement with Novo Nordisk. New Hims patients can access branded options such as Wegovy and branded tirzepatide rather than the compounded GLP-1 products that were previously part of the market.

Ro also has a strong focus on branded GLP-1 medications, but its medication menu is broader. Depending on eligibility and availability, its offerings include Wegovy, Zepbound, Ozempic, oral Wegovy, and the newer orforglipron pill.

The two companies also take somewhat different approaches to care.

Hims is more streamlined. The experience is designed to be relatively straightforward, with an online assessment, provider review, medication access, and ongoing support.

Ro takes a more comprehensive approach. Its program emphasizes medical support, coaching, insurance assistance, and help navigating access to prescription medications.

In other words, Hims may appeal to someone who wants simplicity, while Ro may be more attractive to someone looking for a broader care program.

What Medications Do Hims and Ro Offer?

Both platforms now center their weight-loss programs around branded GLP-1 medications.

The exact medication offered to an individual depends on medical eligibility, prescribing decisions, availability, and other factors.

Wegovy

Wegovy contains semaglutide and is a GLP-1 medication approved for chronic weight management in eligible patients.

Hims offers branded Wegovy, including an oral version, while Ro also provides access to Wegovy depending on eligibility.

Clinical research has demonstrated substantial average weight loss with semaglutide when combined with lifestyle intervention. In the STEP 1 trial, participants receiving semaglutide 2.4 mg experienced an average body-weight reduction of 14.9% over 68 weeks.

Importantly, clinical-trial results should not be interpreted as a guarantee of what an individual patient will experience.

Zepbound

Zepbound contains tirzepatide, which works on both GIP and GLP-1 pathways.

Ro offers Zepbound as part of its branded medication selection. Hims also provides access to branded tirzepatide.

In the SURMOUNT-1 trial, participants receiving tirzepatide experienced substantial average weight loss over 72 weeks, with the highest studied dose producing approximately 20.9% average weight loss.

Again, real-world results can differ considerably from clinical-trial averages.

Does Hims Offer Oral Tirzepatide?

No FDA-approved oral tirzepatide is available as of 2026.

Tirzepatide remains an injectable medication. Hims offers branded injectable tirzepatide, while its oral GLP-1 option is oral semaglutide rather than oral tirzepatide.

This distinction matters because advertisements or websites claiming to offer an FDA-approved oral tirzepatide product may create confusion.

If an online provider advertises an "oral tirzepatide" treatment, check exactly what medication and active ingredient are being offered before making a purchase or beginning treatment.

Do Ro or Hims Prescribe Metformin?

Metformin is an older, widely used medication primarily prescribed for type 2 diabetes. It is sometimes used off-label in certain weight-management situations.

Ro is more likely to include metformin as an adjunct treatment for appropriate patients, including some people with insulin resistance.

Hims has also offered combination oral treatment kits that may include metformin alongside other medications.

However, metformin isn't a substitute for GLP-1 medication, and whether it is appropriate depends on a person's individual medical circumstances.

If metformin is important to your treatment plan, ask the provider specifically whether it is available and medically appropriate during the initial consultation.

How Much Do Hims and Ro Cost for Weight Loss in 2026?

Price is one of the biggest differences people notice when comparing online weight-loss programs.

Both Hims and Ro generally separate the cost of their membership or medical program from the cost of the medication itself.

Hims pricing

Based on the pricing information provided:

About $39 for the first month
Approximately $149 per month afterward
Medication is charged separately
Branded Wegovy may cost around $299 per month
Oral Wegovy may cost around $249 per month
Zepbound may cost around $399 per month

Eligible patients may also be able to use manufacturer savings programs, which can substantially reduce the cost of certain branded medications.

Ro pricing

Ro's Body membership is approximately:

$145 per month when paid monthly
Around $74 per month when prepaid annually

Medication costs are separate and depend on the specific medication and the patient's coverage situation.

One major advantage of Ro is its insurance-support component. Rather than simply providing a prescription, the platform can help patients navigate insurance coverage and medication access.

Why the old compounded-price comparison no longer works

People researching online GLP-1 programs may remember a time when telehealth companies competed heavily on the price of compounded semaglutide and tirzepatide.

That comparison is becoming less useful as major platforms move toward branded medications.

Today, the more relevant question is not simply:

"Which company has the cheapest GLP-1?"

Instead, compare the entire cost:

Membership fees
Medication price
Insurance coverage
Deductibles
Copays or coinsurance
Manufacturer savings programs
Shipping
Provider support
Additional services

A lower membership fee does not necessarily mean a lower overall treatment cost.

Does Insurance Cover Weight-Loss Medication Through Hims or Ro?

Insurance coverage can make a dramatic difference in the final price.

Coverage depends on the patient's specific insurance plan, the medication being prescribed, the medical indication, and the insurer's requirements.

Ro places significant emphasis on helping patients navigate insurance coverage. This can be useful because GLP-1 coverage frequently involves prior authorization, documentation requirements, or other restrictions.

Hims can also work with branded medication savings programs where patients qualify.

Before assuming a medication will be covered, check your insurance policy and ask the provider:

Is the specific medication covered?
Is prior authorization required?
Is the medication covered for weight management?
What deductible applies?
What will the expected copay or coinsurance be?
Can a manufacturer savings program be used?

These questions can prevent unpleasant surprises after enrollment.

Hims vs. Ro: Which Has the Better Medical Experience?

Medication availability is only one part of an online weight-loss program.

The quality and accessibility of medical support can be just as important.

Hims: Simple and streamlined

Hims generally takes a more direct approach.

Patients complete an online health assessment, have their information reviewed by a licensed provider, and may receive a prescription if medically appropriate.

This streamlined structure can be appealing to someone who prefers a relatively simple digital experience.

Ro: More comprehensive support

Ro emphasizes a broader medical program that includes provider care, coaching, and insurance assistance.

For someone who expects to need help navigating insurance, understanding medication options, or making lifestyle changes alongside prescription treatment, this broader model may be appealing.

The best choice depends on how much support you actually want.

Someone looking for a simple prescription-focused experience may prefer a streamlined platform. Someone who wants more assistance throughout the process may prefer a more comprehensive model.

Hims vs. Ro: What About the Women's Options?

Hers is the women's-focused brand operated by the same company behind Hims.

Because of that, its weight-loss medication options largely mirror the broader Hims offering.

Ro, by comparison, operates its weight-loss program under one primary brand rather than creating a separate women's version.

The important distinction is therefore mostly about branding and program presentation, rather than a completely different class of weight-loss medication.

Medication selection and eligibility still depend on individual medical circumstances.

How Effective Are the Medications?

It is important to separate the effectiveness of the medication from the effectiveness of the telehealth platform.

Hims and Ro do not create the clinical effect of semaglutide or tirzepatide. The medications themselves have been studied extensively in randomized clinical trials.

Semaglutide research

The STEP 1 study evaluated once-weekly semaglutide alongside lifestyle intervention.

Participants receiving semaglutide 2.4 mg experienced an average weight loss of 14.9% after 68 weeks, compared with 2.4% in the placebo group.

The results demonstrated that semaglutide can produce meaningful weight reduction for eligible patients when used as part of an appropriate treatment plan.

Tirzepatide research

Tirzepatide has also demonstrated significant weight-loss results in clinical trials.

In SURMOUNT-1, the 15 mg group experienced approximately 20.9% average weight loss after 72 weeks, compared with 3.1% with placebo.

These numbers are useful for understanding the potential of the medications, but they should not be treated as personal predictions.

Individual results can vary based on adherence, dose tolerance, lifestyle factors, treatment duration, medical history, and whether treatment is continued long enough.

What Should You Compare Before Choosing a Provider?

Instead of choosing based only on a promotional price, look at the entire treatment experience.

1. Check the medication first

Make sure you know exactly what medication you would receive.

Ask whether it is:

Branded or compounded
Injectable or oral
FDA-approved for the intended use
Available at your prescribed dose

Do not assume that two programs offering "GLP-1 treatment" provide the same medication.

2. Calculate your real monthly cost

Add the membership fee and medication cost together.

Then check whether insurance, deductibles, copays, or manufacturer savings programs change the calculation.

The cheapest advertised membership isn't necessarily the cheapest complete treatment.

3. Look at insurance support

If your insurance potentially covers your medication, insurance assistance could be worth more than a small difference in membership pricing.

Ask how the platform handles prior authorization and what happens if the initial request is denied.

4. Understand the care model

Find out who you communicate with when you have questions.

Is support provided primarily through:

Health coaches?
Nurses?
Prescribing clinicians?
Scheduled appointments?
Messaging?

A convenient platform is useful, but access to appropriate clinical care matters when medication side effects or treatment questions arise.

5. Check medication availability

A platform may advertise a particular medication but have changing availability.

Ask whether the medication you are interested in is currently available and whether there are additional pharmacy or fulfillment requirements.

Which Is Better: Hims or Ro?

There isn't one universal winner.

Hims may be a better fit if you want:

A streamlined digital experience
Branded GLP-1 options
A relatively simple membership structure
Access to eligible manufacturer savings programs
Less emphasis on a broad coaching program

Ro may be a better fit if you want:

A broader branded GLP-1 selection
More comprehensive medical support
Insurance navigation
Coaching and ongoing weight-management support
Access to additional treatment options when clinically appropriate

The decision ultimately comes down to medication, total cost, insurance, and the level of support you want.

Final Verdict: Hims vs. Ro for Weight Loss

The Hims vs. Ro comparison looks different in 2026 than it did when compounded GLP-1s were a major part of the telehealth market.

Hims has moved toward a branded-medication model with a simpler patient experience, while Ro continues to emphasize a broader medical program, insurance assistance, and a wider branded GLP-1 selection.

Neither platform is automatically better for everyone.

Before enrolling, compare the medication you would actually receive, the full monthly cost, insurance eligibility, savings programs, provider access, and ongoing support. Most importantly, make sure any prescription treatment is medically appropriate for your individual situation.

The best weight-loss program isn't necessarily the one with the lowest advertised price. It's the one that combines an appropriate medication, transparent costs, reliable clinical support, and a treatment approach you can realistically maintain over time.

Sources

Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
U.S. FDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
Pharmacy Times. Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis. https://www.pharmacytimes.com/view/novo-nordisk-drops-hims-hers-inside-the-compounded-glp-1-crisis

Hims vs. Ro for Weight Loss: GLP-1 Pricing, Medications, and Which Option Is Better?